Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$1.43
$0.169913.48%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 36.66M | 21.92M | -3.49M | 21.74M | 23.60M |
| Total Depreciation and Amortization | 3.47M | 5.30M | 2.12M | 3.54M | 3.46M |
| Total Amortization of Deferred Charges | -- | -- | 885.70K | -- | -- |
| Total Other Non-Cash Items | 16.50M | 16.41M | 16.03M | 4.20M | -643.10K |
| Change in Net Operating Assets | -32.72M | -51.09M | 31.22M | 9.33M | -1.10M |
| Cash from Operations | 23.92M | -7.45M | 46.76M | 38.81M | 25.31M |
| Capital Expenditure | -934.30K | -2.71M | -3.69M | -2.96M | -2.58M |
| Sale of Property, Plant, and Equipment | 195.10K | 47.30K | 395.50K | -1.90K | 328.90K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.90M | 1.13M | -14.77M | 5.39M | 3.43M |
| Cash from Investing | -4.63M | -1.53M | -18.06M | 2.43M | 1.18M |
| Total Debt Issued | 1.79B | 500.00M | 834.23M | 930.00M | 3.33B |
| Total Debt Repaid | -1.74B | -437.01M | -1.02B | -819.63M | -3.14B |
| Issuance of Common Stock | 73.17M | -- | 1.74B | 45.30M | -- |
| Repurchase of Common Stock | -- | -40.89M | -1.85B | -- | -66.70M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -12.08M | -11.30M | -10.99M | -11.36M | -11.00M |
| Other Financing Activities | -214.33M | -188.19M | -193.57M | -224.01M | -217.08M |
| Cash from Financing | -17.46M | -21.09M | -38.71M | -15.37M | -16.49M |
| Foreign Exchange rate Adjustments | 2.04M | -548.60K | 6.04M | -2.75M | -3.18M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.87M | -30.62M | -3.98M | 23.13M | 6.82M |
